Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Tadayoshi Takegoshi"'
Autor:
Yoshihito Kita, Masa-aki Kawashiri, Kenji Sakata, Masayuki Tsuchida, Hidekazu Ino, Masaki Okajima, Wataru Omi, Tadayoshi Takegoshi, Mutsuko Takata, Ryota Teramoto, Masakazu Yamagishi, Masayuki Takamura, Hideo Inaba
Publikováno v:
Circulation Journal. 73:1243-1247
Background: Although acute coronary syndrome (ACS) and stroke are known to increase after earthquake, few data exist regarding the effect of earthquake on these cardiovascular events in rural areas. Methods and Results: The Noto Peninsula earthquake
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::20b071f847ea446fce409c075378e23e
https://doi.org/10.1253/circj.cj-08-0812
https://doi.org/10.1253/circj.cj-08-0812
Autor:
Tomio Kametani, Junji Koizumi, Hajime Fujita, Tadayoshi Takegoshi, Takanobu Wakasugi, Ryoyu Takeda, K. Ueda, Tetsuji Sumitani, Makoto Ohta, Akira Watanabe, Takio Ohka, Honin Kanaya, Hiroshi Mabuchi, Senshyu Hifumi, Masami Shimizu, Susumu Miyamoto, Yoshihide Uno, Hideki Origasa
Publikováno v:
Journal of Atherosclerosis and Thrombosis. 12:48-52
Our purpose in this study was to evaluate the new JAS guidelines as a risk assessment tool in Japanese patients with hypercholesterolemia, using the cohort of the Holicos-PAT study. The Holicos-PAT study was designed as a prospective observational st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4251acaf079388f143e4b9255f09c99e
https://doi.org/10.5551/jat.12.48
https://doi.org/10.5551/jat.12.48
Autor:
Masaki Fujimura, Yasukatsu Michishita, Yoshihisa Ishiura, Shigeharu Myou, Kouichi Nobata, Chihiro Yamamori, Kazuyoshi Kurashima, Tadayoshi Takegoshi
Publikováno v:
British Journal of Clinical Pharmacology. 55:504-510
Aims Cough, one of the main symptoms of bronchial asthma, is a chronic airway inflammatory disease with functionally damaged bronchial epithelium. Recently, we established an animal model with cough hypersensitivity after antigen challenge and clearl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::86c530a145fac0a3bdf3ad749f49a822
https://doi.org/10.1046/j.1365-2125.2003.01788.x
https://doi.org/10.1046/j.1365-2125.2003.01788.x
Autor:
Hiroshi Mabuchi, Tadayoshi Takegoshi, Junji Koizumi, Kouji Kajinami, Atsushi Nohara, Akihiro Inazu, Kosei Ueda, Yoshihiro Noji, Toshinori Higashikata, Susumu Miyamoto
Publikováno v:
Atherosclerosis. 163:157-164
The clinical efficacy and safety of pitavastatin (NK-104), a novel HMG-CoA reductase inhibitor, during long-term treatment, were examined in 25 patients (male/female=11/14, mean age=53+/-13 (mean+/-SD) years) with heterozygous familial hypercholester
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb481c30bc8e0580f30ce5feed966348
https://doi.org/10.1016/s0021-9150(01)00765-1
https://doi.org/10.1016/s0021-9150(01)00765-1
Autor:
Junji Koizumi, Hiroshi Mabuchi, Kouji Kajinami, Susumu Miyamoto, Kosei Ueda, Tadayoshi Takegoshi
Publikováno v:
The American Journal of Cardiology. 85:178-183
The clinical efficacy of NK-104, a novel and totally synthetic hydroxymethylglutaryl-coenzyme A reductase inhibitor, was assessed in 30 patients (men/women = 15/15, mean age 51 years) with heterozygous familial hypercholesterolemia. After a placebo p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::213fe42780855e1855a6be44161b6ce5
https://doi.org/10.1016/s0002-9149(99)00656-6
https://doi.org/10.1016/s0002-9149(99)00656-6
Autor:
Tadayoshi Takegoshi, Susumu Miyamoto, K. Ueda, Hiroshi Mabuchi, Masami Shimizu, Junji Koizumi, Kouji Kajinami
Publikováno v:
The American Journal of Cardiology. 82:1489-1495
Familial hypercholesterolemia (FH) is characterized by severe hypercholesterolemia and premature coronary heart disease (CHD). The lower the plasma cholesterol level, the more likely it is that CHD can be prevented or retarded; aggressive cholesterol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::865339c736ef98caa7f953372263efaf
https://doi.org/10.1016/s0002-9149(98)00692-4
https://doi.org/10.1016/s0002-9149(98)00692-4
Autor:
Junji Kobayashi, Tadayoshi Takegoshi, Hayato Tada, Atsushi Nohara, K. Ueda, Hiroshi Mabuchi, Masa-aki Kawashiri, Tohru Noguchi, Kunimasa Yagi, Chiaki Nakanishi, Akihiro Inazu, Takeshi Inoue, Susumu Miyamoto, Mika Mori, Junji Koizumi, Masakazu Yamagishi
Publikováno v:
Atherosclerosis. 236(1)
Familial hypercholesterolemia (FH) is an autosomal dominant disease characterized by hypercholesterolemia, tendon xanthomas, and premature coronary heart disease. FH is caused by mutations of "FH genes," which include the LDL-receptor (LDLR), apolipo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::546b191beda98d1a1aeac00e461962fc
https://pubmed.ncbi.nlm.nih.gov/25014035
https://pubmed.ncbi.nlm.nih.gov/25014035
Autor:
Kunirnasa Yagi, Tadayoshi Takegoshi, Mitsuaki Takeda, Hiroshi Mabuchi, Akihiro Inazu, Masayuki Ohta, Yoshihide Uno, Kouii Kalinami, Junii Koizumi, Kosei Ueda, Susurnu Miyamoto, Ryoyu Takeda, Tatsuo Haraki
Publikováno v:
The American Journal of Cardiology. 76:47A-50A
The long-term clinical efficacy of fluvastatin was assessed in 24 patients with familial hypercholesterolemia over a total treatment period of 104 weeks. Patients received an initial fluvastatin dose of 20 mg/day for 8 weeks, which was increased to 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d65df2f26d0aa4ac5f712fbee54dfd7
https://doi.org/10.1016/s0002-9149(05)80016-5
https://doi.org/10.1016/s0002-9149(05)80016-5
Autor:
Takahiko Aoyama, Takashi Saga, Kazuya Saito, Takanobu Wakasugi, Chikashi Kitoh, Yoshikiyo Yamazaki, Tadayoshi Takegoshi, Toshimi Shimada, Jun-ichi Hirai
Publikováno v:
The Journal of Japan Atherosclerosis Society. 22:729-733
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f327240e8af1a9ae8a92074cfdd6559c
https://doi.org/10.5551/jat1973.22.9-10_729
https://doi.org/10.5551/jat1973.22.9-10_729
Publikováno v:
Internal Medicine. 31:725-730
The effects of the metabolic changes of type 2 diabetic patients on ventricular function, especially diastolic ventricular function were investigated. An examination was performed before and after treatment of 18 diabetic patients divided into 3 grou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9fff534f848d27e04f35691231c9e01
https://doi.org/10.2169/internalmedicine.31.725
https://doi.org/10.2169/internalmedicine.31.725